Compounds > debrisoquin

debrisoquin and lovastatin

debrisoquin has been researched along with lovastatin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belas, F; Chaudhary, AK; Cvetkovic, M; Dempsey, PJ; Fromm, MF; Kim, RB; Leake, B; Roden, DM; Roden, MM; Wandel, C; Wilkinson, GR; Wood, AJ1
Dahl, ML; Eriksson, M; Nordin, C; Sjöberg, S1

Other Studies

2 other study(ies) available for debrisoquin and lovastatin

ArticleYear
Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein.
    Pharmaceutical research, 1999, Volume: 16, Issue:3

    Topics: Animals; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Caco-2 Cells; Cells, Cultured; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple; Enzyme Inhibitors; Humans; Male; Mice; Oxidoreductases, N-Demethylating; Pharmacokinetics; Substrate Specificity

1999
Is the cholesterol-lowering effect of simvastatin influenced by CYP2D6 polymorphism?
    Lancet (London, England), 1997, Jul-05, Volume: 350, Issue:9070

    Topics: Anticholesteremic Agents; Cholesterol; Cytochrome P-450 CYP2D6; Debrisoquin; Enzyme Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Polymorphism, Genetic; Simvastatin

1997